Parkinson's Disease (PD) affects the brain, causing problems with movement. It happens when certain brain cells, called dopaminergic neurons, stop working properly. This study tests a new way to help PD patients by using their own blood cells to create special brain cells, known as neural stem cells. These cells are then changed (or reprogrammed) into DA precursor cells, which are important for movement control. The doctors will inject these cells into the patient's brain to see if it helps with PD symptoms.
Key Points:
- This study lasts up to 12 months and includes several check-ups.
- It's for people aged 30-85 with Parkinson's, who have had the disease for more than 3 years and respond well to a medicine called levodopa.
- Participants should not have other serious health issues or be on certain medications.
How understandable was the trial content above?
Hard to understand
Easy to understand